跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Retro-1
首页
药物
Retro-1
Retro-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Procoagulant peptides
US 8563688 B2
申请人: SCHEIFLINGER FRIEDRICH
优先权: 2008
CN
US
6 件公开
Peptides and their utility in modulation of behavior of cells expressing alpha3beta1 integrins
US 7129052 B1
申请人: US HEALTH
优先权: 2000
US
5 件公开
Methods of using retro-inverso peptides derived from interleukin-6
US 7754688 B2
申请人: MYELOS CORP
优先权: 2006
US
5 件公开
PEPTIDE AND USE THEREOF
US 2022175940 A1
申请人: UNIV NIIGATA
优先权: 2019
CN
EP
US
4 件公开
Method of treating endometriosis
US 10023612 B2
申请人: VALIRX PLC
优先权: 2011
CN
US
4 件公开
Therapeutic agents and methods for cardiovascular disease
US 2006074026 A1
申请人: HAZEN STANLEY L
优先权: 2005
US
4 件公开
UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR BINDING PEPTIDES AND METHODS OF USE
EP 4499666 A4
申请人: US GOV VETERANS AFFAIRS
优先权: 2022
EP
US
WO
3 件公开
HNRNP A3 related peptides and use thereof for diagnosis of rheumatoid arthritis
US 8597955 B2
申请人: SKRINER KARL
优先权: 2008
EP
US
3 件公开
Compositions and methods for derepressing RE1 silencing transcription factor target genes
US 12180255 B2
申请人: ALCAMENA STEM CELL THERAPEUTICS LLC
优先权: 2019
CN
US
3 件公开
Retro-inverso peptides derived from leukemia inhibitory factor
US 7109168 B1
申请人: MYELOS CORP
优先权: 2000
US
3 件公开
第 1 / 4 页
上一页
下一页
药物
反馈